Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (mainland).
Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (mainland).
Med Sci Monit. 2018 Apr 19;24:2360-2367. doi: 10.12659/msm.910058.
BACKGROUND The aim of this study was to determine whether polymorphisms of the Ras-association domain family 1 isoform A (RASSF1A) gene were associated with ovarian cancer and with tumor grade and stage, which affect the prognosis of ovarian cancer, in women in Southern China. MATERIAL AND METHODS Women from Southern China with histologically confirmed, graded and staged ovarian cancer (n=1,375), and cancer-free controls (n=1,227), provided samples of peripheral blood. DNA was extracted from the blood samples, and five tagging single nucleotide polymorphisms (SNPs) (rs4688728G>T, rs72932987C>T, rs1989839C>T, rs2073497A>C, and rs2236947A>C) were evaluated using an online assay-by-design platform. Polymerase chain reaction (PCR) DNA amplification was performed and computational haplotyping analysis of genetic associations between the five tagging SNPs was performed to identify frequent haplotypes in women with ovarian cancer, and the associations with tumor grade and stage. RESULTS In women in Southern China, the CT genotype of rs1989839 was associated with the patients with ovarian cancer (P=0.001), and was significantly correlated with tumor grade and stage (P=0.008). One of the remaining four SNPs studied, rs2073497A>C showed an association with the prognostic factors of grade and stage, but this association did not reach statistical significance. CONCLUSIONS Polymorphisms of the RASSF1A gene, most significantly the CT genotype of rs1989839, might play a role in the development and prognosis of ovarian cancer in women in Southern China. To our knowledge, this is the first study to demonstrate an association between polymorphisms in the RASSF1A gene in ovarian cancer.
本研究旨在探讨 Ras-association 域家族 1 异构体 A(RASSF1A)基因多态性与卵巢癌及其影响卵巢癌预后的肿瘤分级和分期之间的关系,研究对象为中国南方的女性。
本研究纳入了经组织学证实、分级和分期的卵巢癌患者(n=1375)和无癌对照者(n=1227),采集外周血样,提取 DNA,采用在线设计平台对 5 个标签单核苷酸多态性(SNP)(rs4688728G>T、rs72932987C>T、rs1989839C>T、rs2073497A>C 和 rs2236947A>C)进行评估。采用聚合酶链反应(PCR)DNA 扩增,对 5 个标签 SNP 的遗传关联进行计算单体型分析,以鉴定卵巢癌患者中常见的单体型,并分析其与肿瘤分级和分期的关系。
在中国南方女性中,rs1989839 的 CT 基因型与卵巢癌患者相关(P=0.001),且与肿瘤分级和分期显著相关(P=0.008)。在研究的其余 4 个 SNP 中,rs2073497A>C 与分级和分期的预后因素相关,但这种关联没有达到统计学意义。
RASSF1A 基因的多态性,尤其是 rs1989839 的 CT 基因型,可能在中国南方女性的卵巢癌发生和预后中起作用。据我们所知,这是首次证明 RASSF1A 基因多态性与卵巢癌之间存在关联的研究。